FDA Inspection
Biocon LimitedBiocon Limited – FDA Inspection, Jan 24, 2020
Record Details
This FDA Inspection record concerns Biocon Limited, with an inspection on January 24, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Biocon Limited
- Inspection Date
- January 24, 2020
- Product Type
- Drugs
View Company Profile
ID · b985e7a5-5d70-454c-9a38-cd8ce642507c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1118826
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Biocon Limited
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 27, 2024 | Not classified | Office of Inspections and Investigations | |
| July 8, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Biocon Limited
- FDA Inspection 1251543 - 2024-09-27
- FDA Inspection 985205 - 2016-07-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.